QBTS Stock Pops As Wall Street Backs Quantum Rollout
D-Wave Quantum Inc. (QBTS) stock rose 7.18% on September 8, 2026, following positive investor sentiment about its quantum advancements. The company has a market cap of $24.6M, negative profit margins, and $296.6M in cash. BMO Capital initiated coverage with an Outperform rating and a $35 price target, citing real-world applications and government backing.
How this was made
The 30-second read
Why it matters
The combination of analyst upgrade, DOCOMO contract, and government funding creates a multi‑catalyst environment likely to sustain short‑term price momentum.
Market read
The news directly drives QBTS’s price action and may influence sentiment toward the broader quantum‑tech niche.
What to watch
Liquidity risk if cash burn accelerates; reliance on a single telecom client may limit diversification.
Background
Micro‑cap quantum‑computing firm QBTS is trading below analyst price targets despite strong cash position and recent enterprise wins.
Ticker impact
D‑Wave Quantum reported a 7.2% intraday pop after BMO Capital’s coverage upgrade and disclosed a new NTT DOCOMO deployment plus CAD 300k Canadian government funding and a CFO transition.
Expect continued volatility in the $17‑$20 range with upside bias if the DOCOMO deployment scales.
Analyst upgrade and real‑world deployment are fresh catalysts; cash runway is strong, supporting a near‑term rally.
Market effects
Positive signal for quantum‑computing and niche telecom hardware sectors, may lift peer sentiment.
Highlights Canadian government support for quantum tech, modest regional interest.
Shows growing enterprise adoption of quantum annealing, could influence global tech investors.
Counterpoint
The CFO departure could signal internal challenges; the stock may be overbought after the pop.
Key entities
- companyD‑Wave Quantum Inc.
Quantum‑computing hardware provider listed on NASDAQ (QBTS).
- clientNTT DOCOMO
Japanese telecom operator deploying D‑Wave’s annealing technology.
- analystBMO Capital
Initiated coverage with Outperform rating and $35 price target.
